MedPath
HSA Approval

CEFUROXIME-AFT POWDER FOR INJECTION 250MG/VIAL

SIN15156P

CEFUROXIME-AFT POWDER FOR INJECTION 250MG/VIAL

CEFUROXIME-AFT POWDER FOR INJECTION 250MG/VIAL

January 12, 2017

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Therapeutic

Prescription Only

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

J01DC02

cefuroxime

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

Qilu Pharmaceutical Co., Ltd.

Active Ingredients

Cefuroxime sodium 263mg eqv Cefuroxime

250mg

Cefuroxime

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CEFUROXIME-AFT POWDER FOR INJECTION 250MG/VIAL - HSA Approval | MedPath